P H A Halkes
Overview
Explore the profile of P H A Halkes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
286
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Groot A, de Bruin H, Nguyen T, Kappelhof M, de Beer F, Visser M, et al.
J Neurol
. 2020 Aug;
268(1):133-139.
PMID: 32737653
Background: Treatment outside office hours has been associated with increased workflow times for intravenous thrombolysis (IVT) in acute ischemic stroke (AIS). Limited data suggest that this "off-hours effect" also exists...
2.
Halkes P, van Gijn J, Kappelle L, Koudstaal P, Algra A
J Neurol Neurosurg Psychiatry
. 2009 Mar;
80(4):437-9.
PMID: 19289481
A considerable proportion of patients discontinue dipyridamole therapy because of headache. Risk indicators for the development of dipyridamole induced headache were identified by means of an exploratory analysis of data...
3.
Algra A, de Schryver E, Halkes P
Ned Tijdschr Geneeskd
. 2008 Jun;
152(20):1179.
PMID: 18549147
No abstract available.
4.
Halkes P, Gray L, Bath P, Diener H, Guiraud-Chaumeil B, Yatsu F, et al.
J Neurol Neurosurg Psychiatry
. 2008 Jun;
79(11):1218-23.
PMID: 18535024
Objectives: To study the effect of combination therapy with aspirin and dipyridamole (A+D) over aspirin alone (ASA) in secondary prevention after transient ischaemic attack (TIA) or minor stroke of presumed...
5.
de Schryver E, Halkes P
Ned Tijdschr Geneeskd
. 2008 Mar;
152(8):445-53.
PMID: 18361194
Objective: The 'European/Australasian stroke prevention in reversible ischaemia trial' (ESPRIT) aimed to determine whether oral anticoagulation of moderate intensity (target international normalised ratio (INR): 2.0-3.0) is more effective than acetylsalicylic...
6.
Halkes P, Algra A
Cerebrovasc Dis
. 2007 Nov;
24 Suppl 1:107-11.
PMID: 17971645
In this paper, an overview is given of trials with oral anticoagulants and dipyridamole in the secondary prevention after transient ischaemic attack or minor stroke. In patients with atrial fibrillation,...
7.
Halkes P, van Gijn J, Kappelle L, Koudstaal P, Algra A
Lancet Neurol
. 2007 Jan;
6(2):115-24.
PMID: 17239798
Background: Oral anticoagulants are better than aspirin for secondary prevention after myocardial infarction and after cerebral ischaemia in combination with non-rheumatic atrial fibrillation. The European/Australasian Stroke Prevention in Reversible Ischaemia...
8.
Halkes P, van Gijn J, Kappelle L, Koudstaal P, Algra A
Lancet
. 2006 May;
367(9523):1665-73.
PMID: 16714187
Background: Results of trials of aspirin and dipyridamole combined versus aspirin alone for the secondary prevention of vascular events after ischaemic stroke of presumed arterial origin are inconsistent. Our aim...
9.